Sintx Technologies, Inc. (SINT) Stock Price & Analysis
Sintx Technologies, Inc. (SINT) rose 3.86% to USD 2.15 as of June 10, 2026 at 04:33 UTC, according to Nexqual real-time market data.
SINT last closed at USD 2.07; the session ranged USD 2.1–2.18 on volume of 37,160 shares. Market capitalization is $13.33M, with a 52-week range of USD 1.86–6.78 (NCM). Source: Nexqual, June 10, 2026 at 04:33 UTC.
Key Statistics (as of June 10, 2026 at 04:33 UTC)
| Price | USD 2.15 |
|---|---|
| Change | ▲ 3.86% (up) |
| Previous Close | USD 2.07 |
| Open | USD 2.1 |
| Day Range | USD 2.1 – 2.18 |
| 52-Week Range | USD 1.86 – 6.78 |
| Volume | 37,160 shares |
| Market Cap | $13.33M |
| Exchange | NCM |
Technical Analysis (SINT)
Nexqual's technical model rates SINT "STRONG SELL" based on 0 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 04:33 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 38.94 (neutral) |
| vs SMA50 | Below (USD 2.41) |
| MACD | -0.09 (negative) |
Analyst Ratings (SINT)
Wall Street analysts rate SINT "Strong Buy" based on 4 analysts, with a mean price target of USD 9.13 (range USD 6–12), per Nexqual as of June 10, 2026 at 04:33 UTC.
| Consensus Rating | Strong Buy |
|---|---|
| Analyst Count | 4 |
| Mean Target | USD 9.13 |
| High Target | USD 12 |
| Low Target | USD 6 |
| Buy / Hold / Sell | 4 / 0 / 0 |
Earnings (SINT)
| EPS Estimate | USD -0.73 |
|---|---|
| Revenue Estimate | $460,000 |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD -0.7 vs est -0.66 ▼ miss |
| 2025-09-30 | USD -3.46 vs est -0.55 ▼ miss |
| 2025-06-30 | USD -1.05 vs est -0.79 ▼ miss |
Source: Nexqual, June 10, 2026 at 04:33 UTC.
Financials & Fundamentals (SINT)
| Total Revenue | $1.03M |
|---|---|
| Revenue Growth (YoY) | +3.00% |
| Gross Margin | +46.84% |
| Operating Margin | -830.00% |
| Profit Margin | +0.00% |
| ROE | -311.41% |
| Debt / Equity | 360.95 |
| Current Ratio | 1.04 |
| Total Cash | $1.89M |
| Total Debt | $3.26M |
| Free Cash Flow | $-3.70M |
Source: Nexqual, June 10, 2026 at 04:33 UTC.
Financial Health Score (SINT)
Nexqual rates Sintx Technologies, Inc.'s overall financial health "Critical" across five dimensions, as of June 10, 2026 at 04:33 UTC.
| Growth | Critical — Revenue -65% YoY (annual), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Critical — $2M cash vs $3M debt |
| Cash Flow | Weak — FCF negative: -$4M, burning cash |
| Efficiency | Critical — ROE -311%, ROA -73.9% |
Ownership (SINT)
| Insider Ownership | +22.54% |
|---|---|
| Institutional Ownership | +5.28% |
| Shares Outstanding | 6.20M |
| Float | 3.44M |
| Short % of Float | +5.00% |
Source: Nexqual, June 10, 2026 at 04:33 UTC.
Leadership (SINT)
Sintx Technologies, Inc. is led by Eric K. Olson (age 62), CEO & Chairman of the Board, per Nexqual as of June 10, 2026 at 04:33 UTC.
| CEO & Chairman of the Board | Eric K. Olson (age 62) |
|---|---|
| Chief Financial Officer | Kevin Trask (age 39) |
| Chief Investment Officer & Director | Gregg Richard Honigblum (age 62) |
| President | Ryan Elmore (age 50) |
Major Backers & Investors (SINT)
Notable institutional backers of Sintx Technologies, Inc. include Veracity Capital LLC, Fidelity, Xtx Topco Ltd, according to Nexqual as of June 10, 2026 at 04:33 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Veracity Capital LLC | 1.78% |
| Fidelity | 0.58% |
| Xtx Topco Ltd | 0.39% |
| DRW Securities, LLC | 0.28% |
| Broadway Wealth Solutions, Inc. | 0.23% |
| Virtus Wealth Solutions LLC | 0.23% |
| UBS Group AG | 0.11% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 1.5% |
| Geode Capital | 0.74% |
| State Street | 0.31% |
Source: Nexqual, June 10, 2026 at 04:33 UTC.
From Sintx Technologies, Inc.'s Latest SEC 10-K Filing (filed 2026-03-20)
Key Strengths & Strategy (as disclosed to the SEC)
- Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States.
- The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (PEE).
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BOXL | Boxlight Corporation | USD 0.77 | ▲ 13.85% |
| CFOR | OpGen, Inc. | USD 2 | ▲ 300% |
| SXTC | China SXT Pharmaceuticals, Inc. | USD 1.56 | ▲ 8.33% |
| AIHS | Senmiao Technology Limited | USD 1.33 | ▲ 15.65% |
| CETX | Cemtrex Inc. | USD 4.8 | ▼ 13.04% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 04:33 UTC. This page is informational and not investment advice.